BIGBEAR
PHARMACEUTICAL
Pralsetinib inhibits the abnormal activation of RET protein and blocks downstream signaling pathways.
AuthenticGuaranteeFast DeliveryPrivacy The price of Pralsetinib varies depending on the region, medical insurance policies, and drug specifications. In the domestic market, the price is typ···【More】
Update: 24 Mar,2026Source: BigbearViews: 83
The price of pralatinib varies depending on the strength, region, and purchase channel, typically ranging from 30,000 to 50,000 yuan per box. The spec···【More】
Update: 24 Mar,2026Source: BigbearViews: 82
The price of pralatinib varies significantly depending on the drug version, strength, whether it is covered by medical insurance, and the purchase cha···【More】
Update: 24 Mar,2026Source: BigbearViews: 83
Ponatinib is an oral tyrosine kinase inhibitor whose main component is ponatinib hydrochloride. It is indicated for the treatment of hematologic malig···【More】
Update: 16 Mar,2026Source: BigbearViews: 85
Ponatinib is an oral tyrosine kinase inhibitor available in tablet form. It is indicated for the treatment of hematologic malignancies such as Philade···【More】
Update: 16 Mar,2026Source: BigbearViews: 87
Pratinib is an oral tyrosine kinase inhibitor that, through its precise targeted mechanism of action, provides an important treatment option for adult···【More】
Update: 16 Mar,2026Source: BigbearViews: 86
Pratinib is an oral tyrosine kinase inhibitor available in capsule form. It is primarily used for the treatment of adult patients with rearranged duri···【More】
Update: 16 Mar,2026Source: BigbearViews: 90
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
